How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

6,112 results for

Depression Screening Tools

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

61. Efficacy and safety of screening for postpartum depression

for the HTA database. Citation Myers ER, Aubuchon-Endsley N, Bastian LA, Gierisch JM, Kemper AR, Swamy GK, Wald MF, McBroom AJ, Lallinger KR, Gray RN, Green C, Sanders GD. Efficacy and safety of screening for postpartum depression. Rockville: Agency for Healthcare Research and Quality (AHRQ). Comparative Effectiveness Review No. 106. 2013 Authors' objectives To describe the benefits and harms of specific tools and strategies for screening for postpartum depression. Authors' conclusions The potential (...) Efficacy and safety of screening for postpartum depression Efficacy and safety of screening for postpartum depression Efficacy and safety of screening for postpartum depression Myers ER, Aubuchon-Endsley N, Bastian LA, Gierisch JM, Kemper AR, Swamy GK, Wald MF, McBroom AJ, Lallinger KR, Gray RN, Green C, Sanders GD Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made

2013 Health Technology Assessment (HTA) Database.

62. Depression: Perinatal

antidepressant in pregnancy. The first-line antidepressant in both pregnancy and lactation is sertraline and second-line is escitalopram. Fluoxetine is not recommended. Previously, sertraline was first-line and citalopram and fluoxetine were second-line antidepressants for pregnancy and lactation. Escitalopram was not on the preferred list. For pregnant and postpartum women, we now recommend using the Maternal Behavioral Health Screening tool. Previously, depression screening for all adults was done (...) initiative that focuses on pregnant and postpartum women through an infant’s first year of life. Recent research demonstrates that pregnancy and the first year of the infant's life pose increased risks to the mother's mental health and well-being, including depression, anxiety, and domestic violence. MBH screening tools and processes are similar to those used in BHI, but they are tailored for maternal health and include questions about domestic violence. 3 Screening and Diagnosis Routine screening using

2020 Kaiser Permanente Clinical Guidelines

63. Depressive spectrum disorders in cancer: prevalence, risk factors and screening for depression: a critical review. Full Text available with Trip Pro

criteria, the tools used in the studies (e.g. semi-structured psychiatric interview and psychometric questionnaires), as well as the stage and type of cancer. Furthermore, despite the significant health care resources devoted to cancer care and the importance of addressing depressive symptoms, assessment and management of depressive spectrum disorders in cancer patients remains suboptimal.Routine screening and adequate assessment of depressive spectrum disorders is necessary in patients with cancer (...) Depressive spectrum disorders in cancer: prevalence, risk factors and screening for depression: a critical review. Although depression and mood-related disorders are common in persons with cancer, these conditions remain frequently overlooked in clinical practice. Negative consequences of depressive disorder spectrum have been reported (e.g. suicidal ideation, increase physical complications and somatic symptoms, negative influence on prognosis), indicating the need for routine screening

2017 Acta Oncologica

64. Improving discrimination in antepartum depression screening using the Edinburgh Postnatal Depression Scale. (Abstract)

Improving discrimination in antepartum depression screening using the Edinburgh Postnatal Depression Scale. Universal screening of pregnant women for postpartum depression has recently been recommended; however, optimal application of depression screening tools in stratifying risk has not been defined. The current study examines new approaches to improve the ability of the Edinburgh Postnatal Depression Scale (EPDS) to stratify risk for postpartum depression, including alternate cut points, use (...) of a continuous measure, and incorporation of other putative risk factors.An observational cohort study of 4939 women screened both antepartum and postpartum with a negative EPDS screen antepartum(i.e. EPDS<10). The primary outcome was a probable postpartum major depressive episode(EPDS cut-off ≥10). Area under the receiver operating characteristics curve(AUC), sensitivity, specificity, and predictive values were calculated.287 women(5.8%) screened positive for postpartum depression. An antepartum EPDS cut

2017 Journal of Affective Disorders

65. The Hospital Anxiety and Depression Scale (HADS) and the 9-item Patient Health Questionnaire (PHQ-9) as screening instruments for depression in patients with cancer. Full Text available with Trip Pro

The Hospital Anxiety and Depression Scale (HADS) and the 9-item Patient Health Questionnaire (PHQ-9) as screening instruments for depression in patients with cancer. Depression screening in patients with cancer is recommended by major clinical guidelines, although the evidence on individual screening tools is limited for this population. Here, the authors assess and compare the diagnostic accuracy of 2 established screening instruments: the depression modules of the 9-item Patient Health (...) Questionnaire (PHQ-9) and the Hospital Anxiety and Depression Scale (HADS-D), in a representative sample of patients with cancer.This multicenter study was conducted with a proportional, stratified, random sample of 2141 patients with cancer across all major tumor sites and treatment settings. The PHQ-9 and HADS-D were assessed and compared in terms of diagnostic accuracy and receiver operating characteristic (ROC) curves for Diagnostic and Statistical Manual of Mental Disorders, 4th edition diagnosis

2017 Cancer

66. Screening Family and Psychosocial Risk in Pediatric Migraine and Tension-Type Headache: Validation of the Psychosocial Assessment Tool (PAT). (Abstract)

functioning (r = .21). Predictive validity was demonstrated by a significant association between PAT Total scores at baseline with child emotional and behavioral functioning (r = .64), parent anxiety (r = .37), parent depression (r = .42), and family functioning (r = .26) at 6-month follow-up.The PAT is a promising tool for screening psychosocial risk that could facilitate identification of psychosocial treatment needs among youth with recurrent headache at risk for poor outcomes.© 2019 American Headache (...) Screening Family and Psychosocial Risk in Pediatric Migraine and Tension-Type Headache: Validation of the Psychosocial Assessment Tool (PAT). To present data on psychometric properties of the Psychosocial Assessment Tool 2.0_General (PAT), a brief screener for psychosocial risk in families of youth with medical conditions, in youth with headache.Emotional and behavioral disturbances, parent distress, and poor family functioning are common among youth with recurrent migraine and tension-type

2019 Headache

67. Development and validation of a simple screening tool for caregiver grief in dementia caregiving. Full Text available with Trip Pro

Development and validation of a simple screening tool for caregiver grief in dementia caregiving. Loss and grief are experienced by caregivers of persons with dementia (PWD), relating to the ambiguous loss of PWD even when they are still alive and the anticipation of future loss related to their physical death. Such experience of caregiver grief is not easily recognized in clinical practice, despite its association with adverse effects such as caregiver burden, caregiver depression (...) and caregivers' desire to place the PWD in nursing homes. We constructed a simple screening tool - based on factors associated with caregiver grief - to identify caregivers with high grief.Spouses or children of community-dwelling PWD (n = 403) completed self-administered questionnaires containing a well-established grief scale and information related to the caregiver and PWD. We split the study sample into two - the derivation sample (n = 300) was used to identify factors associated with grief (using

2019 BMC Geriatrics

68. Application of Assessment Tools to Examine Mental Health in Workplaces: Job Stress and Depression Full Text available with Trip Pro

and depression, in workplaces. These tools can be used by clinicians or professionals involved in the mental health, occupational safety, or health service fields for running diagnostics or screening tests. (...) Application of Assessment Tools to Examine Mental Health in Workplaces: Job Stress and Depression Despite the fact that the lifetime and yearly prevalence rates of mental illness continue rising, such diseases have only been acknowledged as involved in workplace health issue since the 2000s. Additionally, while the number of recognized cases of mental illnesses is rather low compared to their prevalence, they have a high likelihood of causing significant problems, including fatalities. Many

2018 Psychiatry investigation

69. Cognitive impairment as measured by the THINC-integrated tool (THINC-it): The association with self-reported anxiety in Major Depressive Disorder. (Abstract)

Cognitive impairment as measured by the THINC-integrated tool (THINC-it): The association with self-reported anxiety in Major Depressive Disorder. This study evaluated the association between self-reported anxiety and objective/subjective measures of cognitive performance in adults with Major Depressive Disorder (MDD).Acutely depressed subjects with recurrent MDD (n = 100) and age-, sex-, and education-matched healthy controls (HC; n = 100) between the ages of 18 and 65 completed the cross (...) -sectional validation study of the THINC-integrated tool (THINC-it; ClinicalTrials.gov: NCT02508493). Objective cognitive performance was assessed using the THINC-it, and subjective cognitive impairment with the Perceived Deficits Questionnaire for Depression-5-item. Subjects also completed the Generalized Anxiety Disorder-7-item (GAD-7) questionnaire.Subjects with MDD reported significantly more anxiety symptoms, as assessed by the GAD-7, compared to HC (p < 0.001). Linear regression analysis determined

2018 Journal of Affective Disorders

70. Screening, referral and treatment for depression in patients with coronary heart disease Full Text available with Trip Pro

on a yearly basis, as for any other major risk factor for CHD. A simple tool for initial screening, such as the Patient Health Questionnaire-2 (PHQ-2) or the short-form Cardiac Depression Scale (CDS), can be incorporated into usual clinical practice with minimum interference, and may increase uptake of screening. Patients with positive screening results may need further evaluation. Appropriate treatment should be commenced, and the patient monitored. If screening is followed by comprehensive care (...) higher prevalence of depression in patients with CHD. It is important to recognise depression in patients with CHD in order to provide the best possible care. Asymptomatic patients with significant cardiovascular risk factors (eg, those with diabetes) may also be considered for screening, as they have a high risk of depression. Many self-reported screening tools exist with the aim of detecting possible depression. These include the Patient Health Questionnaire (PHQ-2, PHQ-9), the Cardiac Depression

2013 Clinical Practice Guidelines Portal

71. Postnatal depression

. Definition Postnatal depression refers to the development of a depressive illness following childbirth and may form part of a bipolar or, more usually, a unipolar illness. Musters C, McDonald E, Jones I. Management of postnatal depression. BMJ. 2008 Aug 8;337:a736. http://www.ncbi.nlm.nih.gov/pubmed/18689433?tool=bestpractice.com Postnatal depression is not recognised by current classification systems as a condition in its own right, but the onset of a depressive episode within 4 weeks of childbirth can (...) : results of a family study. Am J Psychiatry. 2006 Sep;163(9):1549-53. http://ajp.psychiatryonline.org/doi/full/10.1176/ajp.2006.163.9.1549 http://www.ncbi.nlm.nih.gov/pubmed/16946179?tool=bestpractice.com Hence, in common usage, depressive episodes occurring within 6-12 months of delivery may be considered to be postnatal depression. History and exam presence of risk factors depressed mood anhedonia decreased energy or increased fatigability suicidal ideation loss of confidence or self-esteem

2019 BMJ Best Practice

72. Screening for depression in cancer patients receiving radiotherapy: Feasibility and identification of effective tools in the NRG Oncology RTOG 0841 trial. Full Text available with Trip Pro

Screening for depression in cancer patients receiving radiotherapy: Feasibility and identification of effective tools in the NRG Oncology RTOG 0841 trial. Brief tools are needed to screen oncology outpatients for depressive symptoms.Patients starting radiotherapy for the first diagnosis of any tumor completed distress screening tools, including the 9-item Patient Health Questionnaire (PHQ-9), the 2-item Patient Health Questionnaire (PHQ-2), the National Comprehensive Cancer Network Distress (...) , and the eligible patients had breast (45%), gastrointestinal (11%), lung (10%), gynecologic (6%), or other cancers (27%). Seventy-five (16.5%) exceeded screening cutoffs for depressive symptoms. Forty-two of these patients completed the SCID. Another 37 patients whose screening was negative completed the SCID. Among the 79 patients completing the SCID, 8 (10.1%) met the criteria for major depression, 2 (2.5%) met the criteria for dysthymia, and 6 (7.6%) met the criteria for an adjustment disorder. The PHQ-2

2016 Cancer

73. Development and validation of the NDDI-E-Y: a screening tool for depressive symptoms in pediatric epilepsy. Full Text available with Trip Pro

Development and validation of the NDDI-E-Y: a screening tool for depressive symptoms in pediatric epilepsy. To validate the revised 12-item revised Neurological Disorders Depression Inventory-Epilepsy for Youth (NDDI-E-Y), a self-report screening tool for depressive symptoms tailored to youth ages 12-17 with epilepsy.Youth at two sites completed the NDDI-E-Y during a routine epilepsy visit. Youth at one site also completed the Children's Depression Inventory-2 (CDI-2). Seizure and demographic (...) -Y were high.Reliability and construct validity were established for the revised 12-item NDDI-E-Y. The NDDI-E-Y is a brief, free measure of depressive symptoms that can be administered during a routine epilepsy visit.Wiley Periodicals, Inc. © 2016 International League Against Epilepsy.

2016 Epilepsia

74. Validation of screening tools for depression and anxiety disorders in a primary care population with high HIV prevalence in Zimbabwe. Full Text available with Trip Pro

Validation of screening tools for depression and anxiety disorders in a primary care population with high HIV prevalence in Zimbabwe. In low income countries in Sub-Saharan Africa there are few validated tools to screen for common disabling mental disorders such as depression and general anxiety disorder (GAD).We validated three screening tools: the Shona Symptom Questionnaire for common mental disorders (SSQ-14), the Patient Health Questionnaire for depression (PHQ-9), and the Generalized (...) -81%) respectively. Internal reliability was high (Cronbach α=0.74). The optimal cutoff for PHQ-9 was ≥11, which provided a sensitivity of 85% (95%CI:78-90%) and specificity of 69% (95%CI:59-77%) against a SCID diagnosis of depression (Cronbach α=0.86). The GAD-7 (optimal cutoff ≥10) had sensitivity and specificity of 89% (95%CI:81-94%) and 73% (95%CI:65-80%) respectively against a SCID diagnosis of GAD (Cronbach α=0.87).Screening tools for depression and GAD had good performance characteristics

2016 Journal of Affective Disorders

75. Two-question screening for depression in older adults

the search. However, we are not provided with the full search terms and, rather than a single search looking for studies evaluating screening tools of depression in older people, the authors used a two stage approach of generating a list of screening tools and then seeking studies for each instrument, using keywords of ‘depression’ and ‘elderly’. They also did not contact experts in the field, ask for unpublished data or include non-English language articles. These deviations from best practice may have (...) Two-question screening for depression in older adults Two-question screening for depression in older adults Search National Elf Service Search National Elf Service » » » » Two-question screening for depression in older adults Mar 31 2017 Posted by This is the second in a series of Mental Elf blogs produced in partnership with the British Journal of Psychiatry. Each month we select a new paper from the BJPsych to be blogged by a young psychiatrist with research experience. We’re really excited

2017 The Mental Elf

76. End-stage Renal Disease and Depression: A Systematic Review

disorder (MDD) at three to more than six times that of the general US population, and Veterans experience MDD at more than twice the rate of the general US population. The Centers for Medicare and Medicaid Services’ (CMS) requires routine depression screening for patients with ESRD. However, due to the lack of system-wide screening tool requirements, there is wide variation in the tools used to initially screen for depression. In addition, there is no established standard guiding the treatment (...) of patients with ESRD and comorbid MDD. Given the wide variation in depression screening and treatment options for Veterans with ESRD, an understanding of the validity of screening tools used in both VA and community settings – and the subsequent depression treatment-related outcomes for Veterans in all US healthcare settings – is vital. Comorbid depression in patients with ESRD is associated with treatment noncompliance, poorer quality of life, worse sleep, increased emergency department (ED) visits

2020 Veterans Affairs - R&D

77. Systematic Review - Relationship of Deployment-related Mild Traumatic Brain Injury to Posttraumatic Stress Disorder, Depressive Disorders, Substance Use Disorders, Suicidal Ideation, and Anxiety Disorders

245 duplicate citations, we screened 1,215 abstracts. Seven hundred forty records were excluded, leaving 475 citations to be reviewed at the full text level. We excluded 434 articles for one or more of the reasons listed above; 41 studies were included in the review. Key Question 1 We identified 11 studies of national samples and 22 studies of geographically diverse samples reporting prevalence and/or severity of PTSD, depressive disorders, substance use disorders, suicidal ideation or attempts (...) , or a positive screen) were generally more prevalent in Veterans with a history of TBI (mTBI or TBI unspecified) vs no-TBI and service members with a history of mTBI vs no-TBI. In studies reporting a higher prevalence in the groups with a history of TBI vs no TBI, differences ranged from 8% to 28%. One study reported a higher prevalence of major depressive disorder in service members with a history of mTBI with loss of consciousness compared to no TBI but similar prevalence for mTBI with altered state

2019 Veterans Affairs Evidence-based Synthesis Program Reports

78. Treatment of Depression in Children and Adolescents

not otherwise specified. We searched five databases and other sources for evidence available from inception to May 29, 2019, dually screened the results, and analyzed eligible studies. Results. We included in our analyses data from 60 studies (94 articles) that met our review eligibility criteria. For adolescents (study participants’ ages range from 12 to 18 years) with MDD, cognitive behavioral therapy (CBT), fluoxetine, escitalopram, and combined fluoxetine and CBT may improve depressive symptoms (1 (...) Treatment of Depression in Children and Adolescents Treatment of Depression in Children and Adolescents: A Systematic Review Comparative Effectiveness Review Number 224 R Comparative Effectiveness Review Number 224 Treatment of Depression in Children and Adolescents: A Systematic Review Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 5600 Fishers Lane Rockville, MD 20857 www.ahrq.gov Contract No. 290-2015-00011-I Prepared by: RTI

2020 Effective Health Care Program (AHRQ)

79. Standardized Library of Depression Outcome Measures

of followup. Additional measurements outside of the windows listed above are recommended as supplemental measures. Events of Interest Adverse Events Depression treatment-related adverse events. Use of a brief, publicly available, validated measurement tool to capture adverse events is recommended. Reported in 12-month intervals. A-4 OMF CATEGORY OUTCOME MEASURE DEFINITION Events of Interest Suicide Ideation & Behavior Selection of ‘several days’, ‘more than half the days’ or ‘nearly every day’ option (...) Standardized Library of Depression Outcome Measures Research White Paper Standardized Library of Depression Outcome MeasuresResearch White Paper Standardized Library of Depression Outcome Measures Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 5600 Fishers Lane Rockville, MD 20857 www.ahrq.gov Contract No. 290-2014-00004-C Prepared by: L&M Policy Research, LLC Washington, DC 20009 With partners: OM1, AcademyHealth Investigators: Richard E

2020 Effective Health Care Program (AHRQ)

80. The impact of care farms on quality of life, depression and anxiety among different population groups: A systematic review Full Text available with Trip Pro

The impact of care farms on quality of life, depression and anxiety among different population groups: A systematic review The impact of care farms on quality of life, depression and anxiety among different population groups: A systematic review - Murray - 2019 - Campbell Systematic Reviews - Wiley Online Library By continuing to browse this site, you agree to its use of cookies as described in our . Search within Search term Search term SYSTEMATIC REVIEW Open Access The impact of care farms (...) on quality of life, depression and anxiety among different population groups: A systematic review Academic Unit of Public Health, Leeds Institute of Health Sciences, University of Leeds, Leeds, UK Academic Unit of Public Health, Leeds Institute of Health Sciences, University of Leeds, Leeds, UK Plant Research International, Wageningen University, Wageningen, The Netherlands Care Farming UK, Bedminster, UK Academic Unit of Public Health, Leeds Institute of Health Sciences, University of Leeds, Leeds, UK

2019 Campbell Collaboration

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>